nivolumab
bms
['melanoma', 'nivo']
baffling real-world results reported at #smr2022 - #adjuvant nivo for stage iiia #melanoma might do better than observation, yet the us data is problematic since the insurance coverage was different between the groups. we need more inclusive results from public health systems 
Medical oncologist, @lemelbaum institute for immuno-oncology. Treating patients with #Melanoma, interested in #Immunotherapy and clinical trials